NCT02759198

A Clinical Trial of YH23537 in Patients With Knee Osteoarthritis

A Randomized, Double-blind, Placebo- and Active-Controlled, Multicenter, Phase 2 Trial to Evaluate the Efficacy and Safety of YH23537 in Patients With Osteoarthritis of the Knee

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 456 (actual)
• Sponsor: Yuhan Corporation · Industry
• Sex: All
• Age: 40 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate efficacy and safety of YH23537 versus celebrex in patients with knee osteoarthritis.

Conditions

• Knee Osteoarthritis

Interventions

Type	Name	Description
DRUG	YH23537	Drug: YH23537 750mg Drug: YH23537 1500mg Drug: YH23537 3000mg
DRUG	Celecoxib	Drug: Celecoxib 200mg
DRUG	YH23537 placebo	Drug: YH23537 750mg placebo Drug: YH23537 1500mg placebo Drug: YH23537 3000mg placebo

Timeline

• Start date: 2016-05-02
• Primary completion: 2017-05-24
• Completion: 2017-09-26
• First posted: 2016-05-03
• Last updated: 2019-01-16

Locations

1 site across 1 country: South Korea